Pharmacy Hazardous Compounding Contingency Southern Nevada Health Care System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), on behalf of the VA Southern Nevada Health Care System (VASNHCS), is conducting Sources Sought market research to identify qualified contractors for the contingency compounding and delivery of antineoplastic hazardous drugs. This effort aims to determine industry availability and capability for a potential five-year Indefinite Quantity Indefinite Delivery (IDIQ) contract, anticipated to begin October 1, 2026. Responses are due by March 19, 2026, 11:00 AM Pacific Time.
Purpose
This notice serves as a market research tool to gather information from firms capable of providing FDA 503A compliant compounding and delivery services for hazardous medications. The insights gained will inform the Government's acquisition strategy for a possible future Request for Quote (RFQ) and help determine appropriate small business set-aside possibilities or whether full and open competition should be utilized.
Scope of Work
The selected vendor will be responsible for the compounding and delivery of antineoplastic hazardous drugs on a contingency basis for approximately 15 patients daily, Monday through Friday. Key requirements include:
- Compounding and delivery of medications with at least 12 hours remaining on the Beyond-Use-Dating (BUD).
- Strict adherence to USP 797, USP 800, and Federal Law for compounding, labeling, and BUD.
- Ability to supply the entire list of compounded chemotherapy medications as needed, as detailed in the Draft Product List.
- Standard orders placed by 12:00 PM PST must be delivered by 9:00 AM the next business day.
- Delivery to the VA Southern Nevada Healthcare System, 6900 North Pecos Road, North Las Vegas, NV 89086.
- Provision of specific supplies compatible with VASNHCS equipment (e.g., BD Alaris tubing, BD PhaSeal CST device).
Contract & Timeline
- Opportunity Type: Sources Sought (Market Research)
- Anticipated Contract Type: Five-year Indefinite Quantity Indefinite Delivery (IDIQ)
- Anticipated Period of Performance: October 1, 2026 – September 30, 2031
- Set-Aside: None specified (to be determined based on market research)
- Response Due: March 19, 2026, 11:00 AM Pacific Time
- Published: March 11, 2026
- Place of Performance: North Las Vegas, NV
Submission Requirements
Interested and qualified firms must submit a statement of interest via email to leah.smith@va.gov. Responses are limited to 10 double-sided pages (including attachments) and must include:
- Business Name and Address
- Business SAM UEI Number
- Point of Contact Name, email address, and contact number
- Business size and Socioeconomic Category (Limitations on Subcontracting will apply)
- Demonstration of ability to meet Government requirements, including product information and capability statements, referencing the DRAFT STATEMENT OF WORK and Draft Product List.
Important Notes
This is strictly market research for informational and planning purposes; it is not a Request for Quote (RFQ) or a commitment to issue a solicitation or award a contract. No questions will be entertained, and no reimbursement will be made for costs associated with responding to this notice. Participation is voluntary, but information gathered may significantly influence the acquisition strategy.